Evidence map›Paper›PMID 40174487›Full record

ArticleSchizophrenia research2025

The problem of missing data for learning health systems focused on first-episode psychosis.

Delbert G Robinson, Nina R Schooler, Majnu John, John Daniel Cahill, Cristina Gomes Gonzalez, Patricia Marcy, Catherine Adams, Mary Distasio, Carla Gerber, Brienne Hackett and 3 more

Abstract read
In one paragraph

Article in Schizophrenia research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Delbert G RobinsonThe Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Departments of Psychiatry and of Molecular Medicine, Hempstead, NY, USA; The Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA; The Zucker Hillside Hospital, Psychiatry Research, Northwell Health System, Glen Oaks, NY, USA. Electronic address: drobinso@northwell.edu.
Nina R SchoolerSUNY Downstate Medical Center, Department of Psychiatry, Brooklyn, NY, USA.
Majnu JohnThe Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA; Hofstra University, Department of Mathematics, Hempstead, NY, USA. Electronic address: mjohn5@northwell.edu.
John Daniel CahillYale School of Medicine, Department of Psychiatry, New Haven, CT, USA; Program for Specialized Treatment in Psychosis, Connecticut Mental Health Center, New Haven, CT, USA. Electronic address: john.cahill@yale.edu.
Cristina Gomes GonzalezThe Vanguard Research Group, Glen Oaks, NY, USA. Electronic address: cgomes@northwell.edu.
Patricia MarcyThe Vanguard Research Group, Glen Oaks, NY, USA. Electronic address: pmarcy@northwell.edu.
Catherine AdamsETCH, East Lansing, MI, USA. Electronic address: adams@etchwellness.org.
Mary DistasioCitrus Health Network, Hialeah, FL, USA. Electronic address: MPadilla@citrushealth.com.
Carla GerberOregon Research Institute, Eugene, OR, USA. Electronic address: cgerber@ori.org.
Brienne HackettEasterseals MORC, Southfield, MI, USA. Electronic address: bhackett@eastersealsmorc.org.
Maria Sanchez NunezSouth County Mental Health Center, Delray Beach, FL, USA. Electronic address: SanchezM@SCMHCINC.ORG.
Vinod H SrihariYale School of Medicine, Department of Psychiatry, New Haven, CT, USA; Program for Specialized Treatment in Psychosis, Connecticut Mental Health Center, New Haven, CT, USA. Electronic address: vinod.srihari@yale.edu.
John M KaneThe Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Departments of Psychiatry and of Molecular Medicine, Hempstead, NY, USA; The Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA; The Zucker Hillside Hospital, Psychiatry Research, Northwell Health System, Glen Oaks, NY, USA. Electronic address: jkane2@northwell.edu.

Funding

Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO)R01MH120594 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI KANE, JOHN M, ROBINSON, DELBERT G · 2019 to 2023
$7.7M
NIMH NIH HHS R01 MH120594
6 · The paper itself

Abstract

backgroundA Learning Health System (LHS) requires data to improve care.

designData are from the ESPRITO LHS that includes 13 US clinics providing coordinated specialty care (CSC) for first-episode psychosis. Causes of missing data examined were: clinic patients not enrolling in ESPRITO, participants prematurely disengaging from treatment and missing patient-reported outcomes.

resultsESPRITO informed consent used a verbal opt-out format. This resulted in a high participant agreement rate (83.5 %) but limitations on data sharing within ESPRITO. During a 6-month period, 15.4 % of ESPRITO participants prematurely terminated treatment. An exploratory analysis revealed factors associated with increased premature termination likelihood: being homeless or having unstable housing, not being prescribed a long-acting injectable antipsychotic and factors associated with decreased premature termination likelihood: having commercial insurance, longer duration of CSC treatment, better scores on the Global Functioning: Social Scale and reporting higher likelihood to attend on the Intent to Attend scale. Examining patient-reported outcomes, rates of missing data with participants still in treatment on the Questionnaire about the Process of Recovery were 26.5 % at first major assessment rising up to 59.8 % on later assessments.

conclusionsMissing data are a substantial problem for first-episode psychosis-focused LHS. LHS designs should consider factors that may influence LHS data participation and a LHS research priority should be developing interventions to decrease missing data. LHS data analyses should also consider potential differential characteristics of individuals who are versus who are not included in LHS data sets.

Indexed as

Learning Health SystemPsychotic DisordersAdolescentAdultAntipsychotic AgentsFemaleHumansMaleMiddle AgedPatient Reported Outcome MeasuresUnited StatesYoung AdultAntipsychotic AgentsEarly psychosisLearning health systemPatient reported outcomesStudy enrollmentTreatment discontinuation

Identifiers

PMID40174487
PMCPMC12051462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.